Ezetimibe
| Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
|---|---|---|---|
| Dyslipidemia Medications (Misc. ) | Ezetimibe | 10mg PO Q24H | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
|---|---|---|---|---|---|---|---|
| 409 | 11 (parent drug); 9 (metabolites) | 22 | N/A | >90 | N/A | N/A | N/A |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00973
- Ezetimibe. In:Lexi-Drugs Online. Hudson (OH): Lexi-Comp, Inc,; [updated 04/23/12; accessed 04/23/12].